Ecole Polytechnique Federale de Lausanne
A new molecule to combat diabetes and obesity
Published in Drug Week, September 18th, 2009
Type 2 diabetes, the most common form of diabetes, is increasing at an alarming state with more than 180 million people affected worldwide. With the rising incidence of obesity, a major risk factor for the onset of type 2 diabetes, this metabolic disorder represents a major health concern. A group from the Ecole Polytechnique Federale de Lausanne, now shows that there may exist new ways to fight these disorders.
The study, published in the current issue of the scientific journal Cell Metabolism (September 2, 2009), demonstrates that activation of the protein -TGR5- can treat type 2 diabetes and reduce weight gain. In collaboration with Prof. Roberto Pellicciari and his...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2009-09-18)
More Articles from Drug Week
- American Academy of Neurology
Cigarettes, not Swedish snuff linked to increased risk of MS - American Academy of Sleep Medicine
Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women - American Gastroenterological Association
GERD negatively impacts sleep quality, results in considerable economic burden - American Gastroenterological Association
Men experience sexual dysfunction during hepatitis C therapy - European Society of Cardiology
PROTECT study - Hospital for Special Surgery
Researchers identify protein involved in causing gum disease, osteoporosis, arthritis - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
